Corporations & securities brief ~ SEC begins formal probe into Merck's handling of Vioxx
Leading Friday's corporations and securities law news, Merck & Co. announced the SEC has started a formal probe into the company's handling of Vioxx . Merck had pulled the painkiller from...
Corporations & securities brief ~ SEC reconsiders Sarbanes-Oxley impact on foreign corporations
Leading Tuesday's corporations and securities law news, SEC Chairman William Donaldson stated in a speech today that the agency is considering changes to the Sarbanes-Oxley Act to ease burden on foreign companies. Companies in both...
A group of seven federal judges will meet in Fort Myers, FL, Thursday to consider how to handle mounting lawsuits over the painkiller Vioxx , which was pulled from the market by manufacturer Merck &...
Corporations & securities brief ~ Record labels sue Kazaa for copyright infringements
In Monday's corporations and securities news, several leading record labels, including EMI, Warner, Sony BMG and Universal, are suing Sharman Networks, the firm behind leading file-swapping software Kazaa in an Australian court. Sharman says it has no control over...
Corporations & securities brief ~ SEC considers charges against ex-Lucent executives
In Tuesday's corporations and securities law news, the SEC is considering bringing civil charges against two former executives of Lucent Technologies Inc. and a third unidentified person over violations of the Foreign Corrupt Practices Act by allegedly participating in...
Pharmaceutical giant Merck and Co., maker of the recalled pain reliever drug Vioxx, said Monday it had been served a subpoena by the US Department of Justice and that it is also the subject of an inquiry by the...
